The successful candidate will have the opportunity to collaborate with a multidisciplinary team that provides a range of therapies, including Mohs micrographic surgery, surgical oncology, reconstructive surgery, dermatologic oncology, radiation therapy, chemotherapy, molecularly targeted therapies, and various forms of immunotherapy. The Cutaneous Oncology section is committed to providing outstanding patient care, through innovative research trials with a strong focus on immunotherapy, to patients with melanoma, Merkel cell carcinoma, and other non-melanoma skin cancers.